Anavex Life Sciences Corp. (AVXL)
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.
$488.42M
Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
38.00
New York, NY
Apr 13, 2006
-11.29
$-0.51
11.81
12.04
0.00%
-11.11
-3.45
3.55
0.00
12.04
-29.32%
-30.62%
Similar stocks (16)
Exelixis, Inc.
EXEL
Viking Therapeutics, Inc.
VKTX
Madrigal Pharmaceuticals, Inc.
MDGL
Axsome Therapeutics, Inc.
AXSM
TG Therapeutics, Inc.
TGTX
Iovance Biotherapeutics, Inc.
IOVA
Novavax, Inc.
NVAX
Cassava Sciences, Inc.
SAVA
Kodiak Sciences Inc.
KOD
Annovis Bio, Inc.
ANVS
INmune Bio, Inc.
INMB
Eyenovia, Inc.
EYEN
BioXcel Therapeutics, Inc.
BTAI
Cognition Therapeutics, Inc.
CGTX
BioVie Inc.
BIVI
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (37)
SPDR S&P Biotech ETF
XBI
0.167783%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1221557096%
iShares Micro-Cap ETF
IWC
0.10803%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.044%
iShares Biotechnology ETF
IBB
0.04352%
Vanguard Russell 2000 Value Index Fund
VTWV
0.03%
iShares Russell 2000 Value ETF
IWN
0.02388%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01603%
ProShares Ultra Nasdaq Biotechnology
BIB
0.013571574314616091%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0096278611%
iShares Russell 2000 Growth ETF
IWO
0.00912%
ProShares Ultra Russell2000
UWM
0.005995285600723859%
ALPS Medical Breakthroughs ETF
SBIO
0.0033%
ProShares UltraPro Russell2000
URTY
0.0029541702156191136%
ProShares Hedge Replication ETF
HDG
0.002515234445011236%
Dimensional U.S. Equity ETF
DFUS
8.600899999999999e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
8.6e-4%
iShares Russell 3000 ETF
IWV
7.5e-4%
Schwab U.S. Broad Market ETF
SCHB
6.126506e-4%
Dimensional U.S. Small Cap ETF
DFAS
5.6452e-4%
Dimensional US Core Equity Market ETF
DFAU
3.7801999999999996e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (16)
Exelixis, Inc.
EXEL
Viking Therapeutics, Inc.
VKTX
Madrigal Pharmaceuticals, Inc.
MDGL
Axsome Therapeutics, Inc.
AXSM
TG Therapeutics, Inc.
TGTX
Iovance Biotherapeutics, Inc.
IOVA
Novavax, Inc.
NVAX
Cassava Sciences, Inc.
SAVA
Kodiak Sciences Inc.
KOD
Annovis Bio, Inc.
ANVS
INmune Bio, Inc.
INMB
Eyenovia, Inc.
EYEN
BioXcel Therapeutics, Inc.
BTAI
Cognition Therapeutics, Inc.
CGTX
BioVie Inc.
BIVI
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (37)
SPDR S&P Biotech ETF
XBI
0.167783%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.1221557096%
iShares Micro-Cap ETF
IWC
0.10803%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.044%
iShares Biotechnology ETF
IBB
0.04352%
Vanguard Russell 2000 Value Index Fund
VTWV
0.03%
iShares Russell 2000 Value ETF
IWN
0.02388%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
iShares Russell 2000 ETF
IWM
0.01603%
ProShares Ultra Nasdaq Biotechnology
BIB
0.013571574314616091%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
Schwab U.S. Small-Cap ETF
SCHA
0.0096278611%
iShares Russell 2000 Growth ETF
IWO
0.00912%
ProShares Ultra Russell2000
UWM
0.005995285600723859%
ALPS Medical Breakthroughs ETF
SBIO
0.0033%
ProShares UltraPro Russell2000
URTY
0.0029541702156191136%
ProShares Hedge Replication ETF
HDG
0.002515234445011236%
Dimensional U.S. Equity ETF
DFUS
8.600899999999999e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
8.6e-4%
iShares Russell 3000 ETF
IWV
7.5e-4%
Schwab U.S. Broad Market ETF
SCHB
6.126506e-4%
Dimensional U.S. Small Cap ETF
DFAS
5.6452e-4%
Dimensional US Core Equity Market ETF
DFAU
3.7801999999999996e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
iShares MSCI USA Small-Cap Multifactor ETF
SMLF
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%